1. Evaluation of potential predictive biomarker for cetuximab in a panel of colorectal cancer patient-derived xenografts (PDX). (December 2016) Authors: Rivera, M.; Hoffmann, J.; Wulf-Goldenberg, A.; Schlag, P.M.; Merk, J.; Walther, W.; Fichtner, I. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗